Central Venous Catheter ThrombosisPHOTO CATNCT06417541
Autopsy and Photon Counting Computed Tomography to Evaluate Thromboses Related to Central Venous Catheters
An observational study of Central Venous Catheter Thrombosis, run by Thomas Kander at 1 site in Sweden.
Trial summary
Central venous (CVC) is essential in modern healthcare but unfortunately associated with complications, including thrombosis. In a recently published study, it was showed that 12 out of 12 deceased patients had subclinical CVK-related thrombosis (Rockholt et al.). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Central Venous Catheter Thrombosis
- What is being tested?
- Diseased patients with an indwelling central venous catheter who is referred to autopsy and Living patients with an indwelling central venous catheter referred to a CT scan without iv contrast
- Type of treatment
- Injection or infusion, Surgery or procedure
- How many people
- 75 participants
- Where
- 1 siteSweden
- Study dates
- 16 Jan 2025to Jun 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Substudy 1: Diseased patients with an indwelling central venous catheter and a clinical indication for autopsy Substudy 2: Living patients with an indwelling central venous catheter who are referred to a CT scan without iv contrast
Who may be able to join
- Diseased patients with an indwelling central venous catheter and a clinical indication for autopsy
- Informed and signed consent from next of kind
Who cannot join
- None
- Substudy 2 Inclusion Criteria
- Living patients with an indwelling central venous catheter who are referred to a CT scan without iv contrast
- Informed and signed consent from the patient
- GFR <15 mL/min/1.73 m2
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Sweden1 site, 1 recruiting
- Recruiting
Intensive and Perioperative Care. Skåne University Hospital. Lund
Lund, Skåne County, 22185
Thomas Kander, Ass. Prof., +46 46 17 11 63, thomas.kander@med.lu.se
Mathias Lazarevic Lindblad, MD, +4646175385, mathias.lazarevic_lindblad@med.lu.se
About this study
Official title: Autopsy and Photon Counting Computed Tomography to Evaluate Thromboses Related to Central Venous Catheters (PHOTO CAT)
Central venous (CVC) is essential in modern healthcare but unfortunately associated with complications, including thrombosis. In a recently published study, it was showed that 12 out of 12 deceased patients had subclinical CVK-related thrombosis (Rockholt et al.). To shed light on this problem, the current studies were designed. In sub-study 1, deceased patients with CVC who are referred for clinical autopsy are included. Before the autopsy, the deceased will be examined with a photon-counting computed tomography (CT) scan and the results will be compared.
In sub-study 2, living patients with CVC who are referred for various CT scans without contrast, are included. After informed consent, the patient will be examined with the photon-counting CT, whose reliability has been validated in Part 1 and the incidence of subclinical CVC-related thrombosis will be reported.
Read the detailed description
Purpose and specific objective The aim of the current project (PHOTO CAT) is to evaluate the prevalence of subclinical thromboses related to central venous catheters (CVCs) using a novel high-resolution photon-counting computed tomography (CT) scan and to evaluate the performance of the photon-counting CT compared to clinical autopsy.
Scientific questions
- Can the photon-counting CT diagnose subclinical CVK-related thromboses detected at later autopsy?
- How common are CVC-related thromboses in autopsies of deceased people with existing CVC?
- How does the performance of the photon counting DT compare to clinical autopsy?
- How common are CVC-related thromboses in a cohort that does photon-counting DT for various reasons and has a CVC?
- Can imaging be improved by adjustments to the DT protocol?
- Can an ultrasound scan on living patients diagnose subclinical CVK-related thrombosis detected by photon-counting CT?
Background CVCs are essential in modern healthcare and have a wide range of applications. They enable direct access to the central bloodstream and are used, among other things, to administer medicines, nutrition and to monitor blood circulation. Unfortunately, they are associated with a variety of complications, including thrombosis. Studies report thrombosis incidences between 5 - 30% in living patients. When the CVC is introduced into the blood vessel, a number of physiological defense systems are initiated. Inflammation and clotting are activated, leading to the formation of a fibrin stocking around the catheter. This can then develop into a catheter-related thrombosis, which in turn can have serious consequences for the patient, such as pulmonary embolism or infection.
Photon-counting DT is the new generation of DT. What distinguishes this from the traditional one is that the radiation through the body is detected with a new type of detector that measures each X-ray, which provides significantly greater precision and resolution for a given radiation dose compared to traditional CT. This is particularly valuable in imaging diagnostics that rely on detailed morphology such as high-resolution CT of lungs. In order to achieve its full potential with as little radiation dose and contrast volume as possible with preserved image resolution, the design of protocols for the photon-counting CT needs to be optimized.
Autopsy studies on CVC-related thrombosis and vascular changes are few. In a case series from 1994, changes in the vessel wall were examined macroscopically and biofilms were assessed with electron microscopy. The presence of fibrin stocking on the surface of all CVCs (n = 72), and wall-mounted thrombosis was reported in 38% of cases. In another autopsy study, Forauer et al. demonstrated severe CVC-related vascular changes that included intima damage with infiltration of media by inflammatory cells and varying degrees of adherent thrombus. Wichmann et al. published data showing a 38% prevalence of macroscopic catheter-related thrombosis in 61 human autopsies. In a recently published autopsy study, we showed that 12 out of 12 cases had CVC-related mural thrombosis at autopsy, with most being located in the distal part of the CVC (Rockholt et al.).
There are also a number of clinical studies that have investigated how common CVC-related thrombosis is using ultrasound. In a well-designed prospective study, 16.9% of ICU patients had subclinical CVK-related thrombosis. The problem with the ultrasound method is that the distal part of the CVC is difficult to visualize with ultrasound, which means that the thrombosis incidence risks being underestimated.
Material and method In an attempt to investigate how common subclinical CVK-related thrombosis, the current studies, include photon-counting CT, were designed.
In substudy 1, photon counting CT is used to examine deceased intensive care patients referred for autopsy on clinical indication, with CVC in-situ. The CT will be focused on the vein with the CVC but a full body examination will also be done . Both examination results will be compared with the clinical autopsy conducted after the examinations. This first part of PHOTO CAT includes Scientific questions 1-3.
In sub-study 2, living patients with CVC who are referred for CT scan without contrast, will be eligable for inclusion. After consent, the study will be carried out with photon counting CT in two phases. First, the examination for which the patient was referred, will be performed. In the second phase, a targeted examination is performed for research purposes of the vein with the CVC. Within 12 hours before or after the CT scan, it is planned to perform an ultrasound scan of the vein where the CVC is located. The aim is to evaluate the performance of ultrasound examination in detecting CVC-related thrombosis, compared to photon-counting CT. Sub-study 2 of PHOTO CAT includes Questions 4-6.
Analysis of data and statistics No one has previously reported photon-counting CT to detect CVC-related thromboses. Therefore, the current exploratory study is planned. The results may form the basis for sample size calculation in future studies.
Significance In patients with CVC, subclinical CVC-related thromboses are very common. These seem to cause surprisingly few clinical problems. However, it should be noted that several of the actual symptoms that CVC-related thrombosis can cause may go unnoticed or misinterpreted as symptoms of the disease that caused the patient's to need of a CVC. It is important to know the true incidence of subclinical CVC-related thrombosis in order to evaluate the risk-benefit of central venous access compared to alternatives (peripheral venous access, midline, PICCLINE, porth-a-cath), and in the development of new less thrombogenic CVC materials.
- Conditions
- Central Venous Catheter Thrombosis
- Being tested
- Diseased patients with an indwelling central venous catheter who is referred to autopsy, Living patients with an indwelling central venous catheter referred to a CT scan without iv contrast
- Keywords
- central venous catheter, thrombosis, photon counting ct
- Medical subject headings
- Upper Extremity Deep Vein Thrombosis, Thrombosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Diseased patients with an indwelling central venous catheter who is referred to autopsyDiagnostic test
Photon counting CT is performed and the results are compared to the results of the autopsy
Living patients with an indwelling central venous catheter referred to a CT scan without iv contrastRadiation
Patients will be investigated using a photon counting CT. Prior to the investigation patients will be investigated with ultrasound. The results from the two modalities will be compared
| Study group | Role | What they receive |
|---|---|---|
| Diseased patients with an indwelling central venous catheter | Sub study 1, Diseased patients with an indwelling central venous catheter Receives: Diagnostic Test: Diseased patients with an indwelling central venous catheter who is referred to autopsy | |
| Living patients with an indwelling central venous catheter | Living patients with an indwelling central venous catheter who are referred to a CT-scan without intravenous contrast Receives: Radiation: Living patients with an indwelling central venous catheter referred to a CT scan without iv contrast |
What is being measured
The primary outcome is the main question the study is designed to answer.
The incidence of venous thrombosis related to a central venous catheter in diseased patients
Venous thrombosis related to a central venous catheter detected at autopsy
Measured: At autopsy
The performance of the photon counting CT on diseased patients
The performance of the photon counting CT will be evaluated by comparing the findings from the CT with the findings from the autopsy
Measured: After death. The CT scan and the autopsy will be performed within 1 week after death
The incidence of venous thrombosis related to a central venous catheter in living patients
The incidence of venous thrombosis related to a central venous catheter in living patients detected with a photon counting CT
Measured: At CT scan
The performance of ultrasound compared to the photon counting CT
The performance of ultrasound compared to the photon counting CT in detecting enous thrombosis related to central venous catheters
Measured: Ultrasound will be performed ±24 hours from the CT
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 May 2024
- Study start16 Jan 2025
- Primary completionJun 2027 (estimated)
- Study completionJun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Central Venous Catheter ThrombosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 75 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Thomas Kander
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Thomas Kander, Region Skane
- Investigators
- Thomas Kander, Principal investigator, Lund University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06417541
- Sponsor's protocol ID
- PHOTO CAT
- Acronym
- PHOTO CAT
- Status last verified
- Apr 2026
- First submitted
- 11 May 2024
- Last updated
- 28 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Upon reasonable request, de-identified individual participant data from this clinical trial will be shared to facilitate scientific collaboration.
Publications
Forauer AR, Theoharis C. Histologic changes in the human vein wall adjacent to indwelling central venous catheters. J Vasc Interv Radiol. 2003 Sep;14(9 Pt 1):1163-8. doi: 10.1097/01.rvi.0000086531.86489.4c.
PubMed 14514808Wichmann D, Heinemann A, Zahler S, Vogel H, Hopker W, Puschel K, Kluge S. Prospective study of device-related complications in intensive care unit detected by virtual autopsy. Br J Anaesth. 2018 Jun;120(6):1229-1236. doi: 10.1016/j.bja.2018.02.031. Epub 2018 Apr 4.
PubMed 29793590Rockholt MM, Naddi L, Badri AM, Englund E, Kander T. Macro- and microscopic changes in veins with short-term central venous catheters: an observational autopsy study. BMC Anesthesiol. 2024 Jan 2;24(1):5. doi: 10.1186/s12871-023-02380-x.
PubMed 38166620
Study at a glance
From the registry record, last updated by the sponsor on 28 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Autopsy and Photon Counting Computed Tomography to Evaluate Thromboses Related to Central Venous Catheters (PHOTO CAT)
- ClinicalTrials.gov ID
- NCT06417541
- Acronym / sponsor ID
- PHOTO CAT / PHOTO CAT
- Conditions
- Central Venous Catheter Thrombosis
- Keywords
- central venous catheter, thrombosis, photon counting ct
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 75 participants (estimated)
- Lead sponsor
- Thomas KanderUniversity, hospital or other
- Study start
- 16 Jan 2025 (actual)
- Primary completion
- Jun 2027 (estimated)
- Study completion
- Jun 2028 (estimated)
- First posted
- 16 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Central venous (CVC) is essential in modern healthcare but unfortunately associated with complications, including thrombosis. In a recently published study, it was showed that 12 out of 12 deceased patients had subclinical CVK-related thrombosis (Rockholt et al.). To shed light on this problem, the current studies were designed. In sub-study 1, deceased patients with CVC who are referred for clinical autopsy are included. Before the autopsy, the deceased will be examined with a photon-counting computed tomography (CT) scan and the results will be compared.
In sub-study 2, living patients with CVC who are referred for various CT scans without contrast, are included. After informed consent, the patient will be examined with the photon-counting CT, whose reliability has been validated in Part 1 and the incidence of subclinical CVC-related thrombosis will be reported.
Detailed description
Purpose and specific objective The aim of the current project (PHOTO CAT) is to evaluate the prevalence of subclinical thromboses related to central venous catheters (CVCs) using a novel high-resolution photon-counting computed tomography (CT) scan and to evaluate the performance of the photon-counting CT compared to clinical autopsy.
Scientific questions
- Can the photon-counting CT diagnose subclinical CVK-related thromboses detected at later autopsy?
- How common are CVC-related thromboses in autopsies of deceased people with existing CVC?
- How does the performance of the photon counting DT compare to clinical autopsy?
- How common are CVC-related thromboses in a cohort that does photon-counting DT for various reasons and has a CVC?
- Can imaging be improved by adjustments to the DT protocol?
- Can an ultrasound scan on living patients diagnose subclinical CVK-related thrombosis detected by photon-counting CT?
Background CVCs are essential in modern healthcare and have a wide range of applications. They enable direct access to the central bloodstream and are used, among other things, to administer medicines, nutrition and to monitor blood circulation. Unfortunately, they are associated with a variety of complications, including thrombosis. Studies report thrombosis incidences between 5 - 30% in living patients. When the CVC is introduced into the blood vessel, a number of physiological defense systems are initiated. Inflammation and clotting are activated, leading to the formation of a fibrin stocking around the catheter. This can then develop into a catheter-related thrombosis, which in turn can have serious consequences for the patient, such as pulmonary embolism or infection.
Photon-counting DT is the new generation of DT. What distinguishes this from the traditional one is that the radiation through the body is detected with a new type of detector that measures each X-ray, which provides significantly greater precision and resolution for a given radiation dose compared to traditional CT. This is particularly valuable in imaging diagnostics that rely on detailed morphology such as high-resolution CT of lungs. In order to achieve its full potential with as little radiation dose and contrast volume as possible with preserved image resolution, the design of protocols for the photon-counting CT needs to be optimized.
Autopsy studies on CVC-related thrombosis and vascular changes are few. In a case series from 1994, changes in the vessel wall were examined macroscopically and biofilms were assessed with electron microscopy. The presence of fibrin stocking on the surface of all CVCs (n = 72), and wall-mounted thrombosis was reported in 38% of cases. In another autopsy study, Forauer et al. demonstrated severe CVC-related vascular changes that included intima damage with infiltration of media by inflammatory cells and varying degrees of adherent thrombus. Wichmann et al. published data showing a 38% prevalence of macroscopic catheter-related thrombosis in 61 human autopsies. In a recently published autopsy study, we showed that 12 out of 12 cases had CVC-related mural thrombosis at autopsy, with most being located in the distal part of the CVC (Rockholt et al.).
There are also a number of clinical studies that have investigated how common CVC-related thrombosis is using ultrasound. In a well-designed prospective study, 16.9% of ICU patients had subclinical CVK-related thrombosis. The problem with the ultrasound method is that the distal part of the CVC is difficult to visualize with ultrasound, which means that the thrombosis incidence risks being underestimated.
Material and method In an attempt to investigate how common subclinical CVK-related thrombosis, the current studies, include photon-counting CT, were designed.
In substudy 1, photon counting CT is used to examine deceased intensive care patients referred for autopsy on clinical indication, with CVC in-situ. The CT will be focused on the vein with the CVC but a full body examination will also be done . Both examination results will be compared with the clinical autopsy conducted after the examinations. This first part of PHOTO CAT includes Scientific questions 1-3.
In sub-study 2, living patients with CVC who are referred for CT scan without contrast, will be eligable for inclusion. After consent, the study will be carried out with photon counting CT in two phases. First, the examination for which the patient was referred, will be performed. In the second phase, a targeted examination is performed for research purposes of the vein with the CVC. Within 12 hours before or after the CT scan, it is planned to perform an ultrasound scan of the vein where the CVC is located. The aim is to evaluate the performance of ultrasound examination in detecting CVC-related thrombosis, compared to photon-counting CT. Sub-study 2 of PHOTO CAT includes Questions 4-6.
Analysis of data and statistics No one has previously reported photon-counting CT to detect CVC-related thromboses. Therefore, the current exploratory study is planned. The results may form the basis for sample size calculation in future studies.
Significance In patients with CVC, subclinical CVC-related thromboses are very common. These seem to cause surprisingly few clinical problems. However, it should be noted that several of the actual symptoms that CVC-related thrombosis can cause may go unnoticed or misinterpreted as symptoms of the disease that caused the patient's to need of a CVC. It is important to know the true incidence of subclinical CVC-related thrombosis in order to evaluate the risk-benefit of central venous access compared to alternatives (peripheral venous access, midline, PICCLINE, porth-a-cath), and in the development of new less thrombogenic CVC materials.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Diseased patients with an indwelling central venous catheter | – | Diagnostic Test: Diseased patients with an indwelling central venous catheter who is referred to autopsySub study 1, Diseased patients with an indwelling central venous catheter |
| Living patients with an indwelling central venous catheter | – | Radiation: Living patients with an indwelling central venous catheter referred to a CT scan without iv contrastLiving patients with an indwelling central venous catheter who are referred to a CT-scan without intravenous contrast |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Substudy 1: Diseased patients with an indwelling central venous catheter and a clinical indication for autopsy Substudy 2: Living patients with an indwelling central venous catheter who are referred to a CT scan without iv contrast
Key inclusion criteria (2 listed)
- Diseased patients with an indwelling central venous catheter and a clinical indication for autopsy
- Informed and signed consent from next of kind
Key exclusion criteria (5 listed)
- None
- Substudy 2 Inclusion Criteria
- Living patients with an indwelling central venous catheter who are referred to a CT scan without iv contrast
- Informed and signed consent from the patient
- GFR <15 mL/min/1.73 m2
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Diseased patients with an indwelling central venous catheter who is referred to autopsyPhoton counting CT is performed and the results are compared to the results of the autopsy | Diagnostic test | Diseased patients with an indwelling central venous catheter |
| Living patients with an indwelling central venous catheter referred to a CT scan without iv contrastPatients will be investigated using a photon counting CT. Prior to the investigation patients will be investigated with ultrasound. The results from the two modalities will be compared | Radiation | Living patients with an indwelling central venous catheter |
Primary outcome
The incidence of venous thrombosis related to a central venous catheter in diseased patients
Time frame: At autopsy
Venous thrombosis related to a central venous catheter detected at autopsy
The performance of the photon counting CT on diseased patients
Time frame: After death. The CT scan and the autopsy will be performed within 1 week after death
The performance of the photon counting CT will be evaluated by comparing the findings from the CT with the findings from the autopsy
The incidence of venous thrombosis related to a central venous catheter in living patients
Time frame: At CT scan
The incidence of venous thrombosis related to a central venous catheter in living patients detected with a photon counting CT
The performance of ultrasound compared to the photon counting CT
Time frame: Ultrasound will be performed ±24 hours from the CT
The performance of ultrasound compared to the photon counting CT in detecting enous thrombosis related to central venous catheters
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Apr 2026.
- Background: PubMed 14514808Forauer AR, Theoharis C. Histologic changes in the human vein wall adjacent to indwelling central venous catheters. J Vasc Interv Radiol. 2003 Sep;14(9 Pt 1):1163-8. doi: 10.1097/01.rvi.0000086531.86489.4c.
- Background: PubMed 29793590Wichmann D, Heinemann A, Zahler S, Vogel H, Hopker W, Puschel K, Kluge S. Prospective study of device-related complications in intensive care unit detected by virtual autopsy. Br J Anaesth. 2018 Jun;120(6):1229-1236. doi: 10.1016/j.bja.2018.02.031. Epub 2018 Apr 4.
- Background: PubMed 38166620Rockholt MM, Naddi L, Badri AM, Englund E, Kander T. Macro- and microscopic changes in veins with short-term central venous catheters: an observational autopsy study. BMC Anesthesiol. 2024 Jan 2;24(1):5. doi: 10.1186/s12871-023-02380-x.
- Individual participant dataSharing planned: Yes. Upon reasonable request, de-identified individual participant data from this clinical trial will be shared to facilitate scientific collaboration.
Related trials for Central Venous Catheter Thrombosis
RecruitingPhase 3
Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)
Venous Thromboembolism (VTE)
Not yet recruitingObservational study
Efficacy and Safety of Peripherally Inserted Central Venous Catheters
Critical Illness, Catheter-Related Infections
Not yet recruiting
Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Intensive Care (COMPAXE-HNF)
Congenital Heart Disease, Unfractionated Heparin
Recruiting
A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer
Adult Cancer Patients, Right Atrial Clot
Not yet recruitingPhase 4
Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)
Hemodialysis Access Failure, Kidney Disease, End-Stage
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Thomas Kander principal investigator
Lund University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Central Venous Catheter Thrombosis, run by Thomas Kander at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Thomas Kander, PhD (+4646171163, thomas.kander@med.lu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The incidence of venous thrombosis related to a central venous catheter in diseased patients (time frame: At autopsy). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06417541, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2026.